Management of Elevated White Blood Cell Count

Initial Assessment and Emergency Management

The American College of Physicians recommends determining whether leukocytosis represents a benign reactive process or a hematologic malignancy, and whether immediate intervention is needed for hyperleukocytosis (>100,000/μL), which constitutes a medical emergency requiring aggressive hydration and cytoreduction 1, 2
Hyperleukocytosis (>100,000/μL) represents a medical emergency due to risk of brain infarction and hemorrhage from leukostasis, requiring immediate intervention 2

Aggressive IV hydration at 2.5-3 liters/m²/day is the cornerstone of initial management for hyperleukocytosis, titrated based on fluid balance, clinical status, and WBC count 1, 2, 3
Hydroxyurea at 50-60 mg/kg/day should be started concurrently to achieve 50% WBC reduction within 1-2 weeks and rapidly reduce counts to <10-20 × 10⁹/L 1, 2, 3
Leukapheresis should be considered only for symptomatic leukostasis (respiratory distress, altered mental status, visual changes) and can achieve 30-80% WBC reduction within hours 1, 3
The National Comprehensive Cancer Network recommends risk stratification based on WBC count for Acute Lymphoblastic Leukemia (ALL), followed by multi-agent induction chemotherapy 4
For leukocytosis secondary to infection or inflammation, treatment should target the primary process 2
The Centers for Disease Control and Prevention recommends that in HIV-infected patients with bacterial pneumonia, the WBC elevation may be relative to baseline in advanced disease, and a left shift may be present 5

Never perform leukapheresis in acute promyelocytic leukemia (APL) due to risk of fatal hemorrhage 1, 2, 3
Never delay hydration and cytoreduction while waiting for definitive diagnosis in hyperleukocytosis 1
Do not use leukapheresis in APL without extreme caution due to hemorrhage risk 1, 2, 3
Definitive therapy in acute leukemia should not be delayed after initial WBC reduction 2